Phase I study of VR647 in patients with Asthma
Phase of Trial: Phase I
Latest Information Update: 24 Jan 2017
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Adverse reactions
- 24 Jan 2017 According to a Vectura media release, this study is expected to initiate in H1 2017.
- 24 Jan 2017 According to a Vectura media release, company has received an Investigational New Drug (IND) approval from the US Food and Drug Administration (FDA) to conduct this study.
- 22 Nov 2016 According to a Vectura Group plc media release, the IND filing is anticipated by the end of 2106.